Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhenyuan Pharmaceutical is a prominent Chinese pharmaceutical enterprise with a legacy tracing back to the historic Zhenyuantang drugstore, founded in 1752 during the Qing Dynasty. Publicly traded on the Shenzhen Stock Exchange as Zhejiang Zhenyuan Share Co., Ltd., the company operates an integrated business model spanning drug manufacturing, wholesale distribution, and retail health services. Its industrial subsidiary is a major production base for anti-infective medications, specializing in macrolide, aminoglycoside, and cephalosporin antibiotics such as Roxithromycin and Azithromycin. Beyond chemical active pharmaceutical ingredients (APIs) and preparations, the company produces traditional Chinese patent medicines and medical devices for domestic and international markets. Zhenyuan Pharmaceutical is recognized as a national high-tech enterprise and leverages its time-honored brand and large-scale manufacturing facilities in Shaoxing to maintain a significant presence in the global healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhenyuan Pharmaceutical.